Summary & Overview
CPT 3328F: Cardiac Device Quality Measure
CPT code 3328F is a performance reporting code tied to cardiac device management and quality measurement. As a CPT Category II–style formatted code (ending with a letter), it denotes a standardized clinical measure rather than a standalone billable procedure. Nationally, such codes matter because they support quality tracking, payment adjustments tied to performance programs, and standardized reporting across payers and health systems.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will gain a concise overview of the code’s clinical context and relevance to cardiac device follow-up and quality reporting, along with an outline of what to expect in payer coverage and benchmarking discussions when available. The publication will cover typical reporting use cases, alignment with quality programs, and where to look for payer-specific policy details.
Data elements that are not provided in the input—such as explicit code description text, common modifiers, associated taxonomies, ICD-10 diagnoses, related codes, and detailed service line information—are noted as unavailable. The national perspective focuses on the role of CPT code 3328F in cardiac device quality measurement and the implications for reporting across major commercial and public payers.
Billing Code Overview
CPT code 3328F represents a performance or quality reporting measure related to cardiac device management. The description for this code is not provided beyond the code identifier; therefore the service type is inferred as a cardiac device-related quality measure and the typical site of service is inpatient or outpatient cardiac care settings where device follow-up and reporting occur.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 72-year-old patient with symptomatic atrial fibrillation is evaluated in the electrophysiology clinic after recurrent palpitations and syncope. The cardiology team determines that the patient requires implantation of a permanent pacemaker or an implantable cardioverter-defibrillator (ICD) system. The procedure is scheduled in the hospital operating room or cardiac catheterization laboratory under conscious sedation or general anesthesia. Vascular access is obtained via the subclavian or cephalic vein, leads are positioned under fluoroscopic guidance into the right atrium and/or right ventricle (and coronary sinus if biventricular pacing is indicated), lead parameters confirmed, and the pulse generator is implanted in a subcutaneous or submuscular pocket. Post-procedure monitoring occurs in the post-anesthesia care unit with device interrogation and programming prior to discharge or transfer to the inpatient cardiology floor. Device implantation workflows include pre-procedure consent, device selection, intra-procedural fluoroscopy, lead testing, pocket closure, device interrogation, and documentation of device model and serial numbers.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable E/M service by the same physician on the same day of the procedure | Used when a distinct evaluation and management visit is provided on the same day as device implantation. |